Healthcare -
Biotechnology - NASDAQ - US
$ 69.97
3.54 %
$ 3.78 B
Market Cap
-98.55
P/E
ACLX - STOCK-BASED COMPENSATION
Stock-based Compensation ACLX - Arcellx, Inc.
41.8 M
LAST VALUE
148.74%
2 YEAR CAGR
263.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR